Vor Biopharma VOR Other Commercial Liabilities
Other Commercial Liabilities at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's other commercial liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's other commercial liabilities?
- Vor Biopharma (VOR) reported other commercial liabilities of $14.73M in Q1 2026.
- How has Vor Biopharma's other commercial liabilities changed year-over-year?
- Vor Biopharma's other commercial liabilities increased by 69.6% year-over-year, from $8.69M to $14.73M.
- What is the long-term trend for Vor Biopharma's other commercial liabilities?
- Over 5 years (2020 to 2025), Vor Biopharma's other commercial liabilities has grown at a 25.9% compound annual growth rate (CAGR), from $6.26M to $19.76M.